Suchergebnisse - "Palmieri, Salvatore"

PubPharm (5)

1

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma : a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials

enthalten in: Haematologica | 2024

von Gentile, M. | Vigna, E. | Palmieri, S. | +44

2

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

enthalten in: Hematological oncology | 2022

von Bruzzese, A. | Derudas, D. | Galli, M. | +57

3

Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients

enthalten in: European journal of haematology | 2022

von Morabito, F. | Zamagni, E. | Conticello, C. | +41

4

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy : Analysis of 919 Cases Outside Clinical Trials

enthalten in: Frontiers in oncology | 2022

von Morabito, F. | Zamagni, E. | Conticello, C. | +45

5

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma : Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

enthalten in: Haematologica | 2021

von Gentile, M. | Specchia, G. | Derudas, D. | +53

1
[1]